Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-16

Clinical Trial Update: Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis

View source ↗

Summary

A head-to-head clinical trial comparing changes in inflammatory proteins in the aqueous humor of eyes treated with Avastin (bevacizumab) versus Lucentis (ranibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Lucentis (ranibizumab)

Snippet

Sponsor: University of British Columbia | Conditions: Proliferative Diabetic Retinopathy (PDR) | Status: COMPLETED